Oct 19 Roche Holding AG :
* FDA approves Genentech's cancer immunotherapy Tecentriq (atezolizumab) for people with a specific type of metastatic lung cancer
* Genentech- FDA approved Tecentriq for treatment of metastatic NSCLC who have disease progression during or following platinum-containing chemo Source text for Eikon: Further company coverage:
Puerto Rico oversight board rejects $9 bln debt restructuring deal -WSJ
June 27 The federal board overseeing Puerto Rico's finances disapproved a $9 billion debt restructuring deal covering the bankrupt U.S. territory's public power monopoly, The Wall Street Journal reported on Tuesday, citing people familiar with the matter.